Nama Chemicals Past Earnings Performance
Past criteria checks 0/6
Nama Chemicals's earnings have been declining at an average annual rate of -44.7%, while the Chemicals industry saw earnings growing at 8.3% annually. Revenues have been declining at an average rate of 2.9% per year.
Key information
-44.7%
Earnings growth rate
-44.7%
EPS growth rate
| Chemicals Industry Growth | 40.7% |
| Revenue growth rate | -2.9% |
| Return on equity | -43.3% |
| Net Margin | -22.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Estimating The Intrinsic Value Of Nama Chemicals Company (TADAWUL:2210)
Dec 18
Nama Chemicals (TADAWUL:2210) Is Doing The Right Things To Multiply Its Share Price
Apr 05Returns Are Gaining Momentum At Nama Chemicals (TADAWUL:2210)
Dec 10Is Nama Chemicals' (TADAWUL:2210) 133% Share Price Increase Well Justified?
Mar 17If You Had Bought Nama Chemicals (TADAWUL:2210) Stock Three Years Ago, You Could Pocket A 100% Gain Today
Dec 01
Revenue & Expenses Breakdown
How Nama Chemicals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 384 | -87 | 77 | 0 |
| 30 Jun 24 | 377 | -89 | 79 | 0 |
| 31 Mar 24 | 412 | -168 | 81 | 0 |
| 31 Dec 23 | 445 | -152 | 80 | 0 |
| 30 Sep 23 | 462 | -113 | 74 | 0 |
| 30 Jun 23 | 505 | -68 | 74 | 0 |
| 31 Mar 23 | 535 | -15 | 76 | 0 |
| 31 Dec 22 | 577 | 37 | 77 | 0 |
| 30 Sep 22 | 594 | 58 | 84 | 0 |
| 30 Jun 22 | 596 | 68 | 83 | 0 |
| 31 Mar 22 | 564 | 51 | 82 | 0 |
| 31 Dec 21 | 554 | 28 | 84 | 0 |
| 30 Sep 21 | 535 | 0 | 78 | 0 |
| 30 Jun 21 | 500 | -15 | 74 | 0 |
| 31 Mar 21 | 482 | -28 | 66 | 0 |
| 31 Dec 20 | 439 | -45 | 61 | 0 |
| 30 Sep 20 | 449 | -1 | 43 | 0 |
| 30 Jun 20 | 468 | 3 | 44 | 0 |
| 31 Mar 20 | 498 | 5 | 47 | 0 |
| 31 Dec 19 | 526 | 10 | 54 | 0 |
| 30 Sep 19 | 545 | -27 | 71 | 0 |
| 30 Jun 19 | 563 | -20 | 71 | 0 |
| 31 Mar 19 | 591 | 5 | 76 | 0 |
| 31 Dec 18 | 624 | 35 | 69 | 0 |
| 30 Sep 18 | 645 | 59 | 72 | 0 |
| 30 Jun 18 | 653 | 57 | 73 | 0 |
| 31 Mar 18 | 650 | 30 | 72 | 0 |
| 31 Dec 17 | 599 | -2 | 71 | 0 |
| 30 Sep 17 | 551 | -736 | 73 | 0 |
| 30 Jun 17 | 508 | -765 | 73 | 0 |
| 31 Mar 17 | 470 | -793 | 74 | 0 |
| 31 Dec 16 | 453 | -811 | 77 | 0 |
| 30 Sep 16 | 445 | -110 | 71 | 0 |
| 30 Jun 16 | 453 | -103 | 71 | 0 |
| 31 Mar 16 | 446 | -65 | 70 | 0 |
| 31 Dec 15 | 460 | -75 | 68 | 0 |
| 30 Sep 15 | 531 | -95 | 74 | 0 |
| 30 Jun 15 | 585 | -94 | 77 | 0 |
| 31 Mar 15 | 624 | -129 | 80 | 0 |
| 31 Dec 14 | 675 | -112 | 86 | 0 |
| 30 Sep 14 | 676 | -83 | 87 | 0 |
| 30 Jun 14 | 692 | -72 | 92 | 0 |
| 31 Mar 14 | 717 | -34 | 94 | 0 |
| 31 Dec 13 | 744 | -44 | 97 | 0 |
Quality Earnings: 2210 is currently unprofitable.
Growing Profit Margin: 2210 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2210 is unprofitable, and losses have increased over the past 5 years at a rate of 44.7% per year.
Accelerating Growth: Unable to compare 2210's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2210 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-55.4%).
Return on Equity
High ROE: 2210 has a negative Return on Equity (-43.31%), as it is currently unprofitable.